Surufatinib in advanced well-differentiated neuroendocrine tumors: a multicenter, single-arm, open-label, phase Ib/II trial
Xu, Jian Ming, Li, Jie, Bai, Chun-Mei, Xu, Nong, Zhou, Zhiwei, Li, Zhiping, Zhou, Caicun, Jia, Ru, Lu, Ming, Cheng, Yuejuan, Mao, Chenyu, Wang, Wei, Cheng, Ke, Su, Chunxia, Hua, Ye, Qi, Chuan, Li, JinJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-2994
Date:
March, 2019
File:
PDF, 691 KB
2019